Glenside, PA, United States of America

Ellen W Baxter

This inventor holds 14 USPTO granted patents. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Ortho Pharmaceutical Corporation. Active years: 1996-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellen W Baxter. Retrieved from https://idiyas.com/inventor/ellen-w-baxter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 71.4

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 1996-2013

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Ellen W Baxter - Pioneering Innovations in Glenside, PA

Introduction: Ellen W Baxter is a visionary inventor based in Glenside, PA, known for her groundbreaking contributions to various fields.

Latest Patents: Ellen W Baxter holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience in the industry, Ellen has successfully brought numerous inventions from concept to market, revolutionizing the way we approach everyday challenges.

Collaborations: Throughout her career, Ellen W Baxter has collaborated with leading research institutions, universities, and companies to further develop and refine her inventions, solidifying her reputation as a collaborative and innovative inventor.

Conclusion: Ellen W Baxter's passion for innovation and dedication to creating impactful solutions have cemented her status as a trailblazing inventor in Glenside, PA, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…